Interleukin-1 receptor antagonist anakinra proves long-lasting efficacy in the treatment of refractory adult onset still's disease

被引:0
|
作者
Naumann, L. [1 ]
Feist, E. [1 ]
Natusch, A. [2 ]
Krause, A. [2 ]
Buttgereit, F. [1 ]
Burmester, G. [1 ]
机构
[1] Univ Berlin Med, Charite, Berlin, Germany
[2] Univ Berlin Med, Charite, Clin Rheumatol Berlin Buch & Immanuel Krankenhaus, Berlin, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:434 / 435
页数:2
相关论文
共 50 条
  • [1] IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease
    Naumann, L.
    Feist, E.
    Natusch, A.
    Langen, S.
    Krause, A.
    Buttgereit, F.
    Burmester, G-R
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (02) : 466 - 467
  • [2] Adult-onset Still's disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra
    Raffeiner, Bernd
    Botsios, Costantino
    Dinarello, Charles
    Ometto, Francesca
    Punzi, Leonardo
    Ramonda, Roberta
    JOINT BONE SPINE, 2011, 78 (01) : 100 - 101
  • [3] Dermal Interleukin-1 Expression and Effective and Long-lasting Therapy with Interleukin-1 Receptor Antagonist Anakinra in Schnitzler Syndrome
    Volz, Thomas
    Woelbing, Florian
    Fischer, Joerg
    Braun, Martin
    Maggoschitz, Iryna
    Schaller, Martin
    Berneburg, Mark
    Biedermann, Tilo
    ACTA DERMATO-VENEREOLOGICA, 2012, 92 (04) : 393 - 394
  • [4] Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra)
    El-Osta, Hazem
    Janku, Filip
    Kurzrock, Razelle
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1485 - 1488
  • [5] SUCCESSFUL TREATMENT OF REFRACTORY ADULT ONSET STILL'S DISEASE WITH ANAKINRA
    Brusch, Anna
    Hollingsworth, Peter
    Mclean-Tooke, Andrew
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 2 - 3
  • [6] Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease:: preliminary experience in France
    Lequerre, T.
    Quartier, P.
    Rosellini, D.
    Alaoui, F.
    De Bandt, M.
    Mejjad, O.
    Kone-Paut, I.
    Michel, M.
    Dernis, E.
    Khellaf, M.
    Limal, N.
    Job-Deslandre, C.
    Fautrel, B.
    Le Loet, X.
    Sibilia, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (03) : 302 - 308
  • [7] Interleukin-1 receptor antagonist anakinra in the treatment of neonatal onset multisystem inflammatory disease.
    Dailey, NK
    Aksentijevich, I
    Chae, JJ
    Wesley, R
    Snyder, C
    Magalnick, M
    Watford, WT
    Gelabert, A
    Jones, J
    Pham, TH
    Hawkins, PN
    Adams, BS
    Moore, TL
    Fuhlbrigge, RC
    Shaham, B
    Lovell, DK
    Jarvis, J
    Stein, LD
    Vehe, RK
    Gardner, G
    Hannan, W
    Warren, RW
    O'Shea, JJ
    Kastner, DL
    Goldbach-Mansky, R
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S440 - S440
  • [8] Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in Korean patients with adult-onset Still's disease.
    Youm, Ji-Youn
    Woo, Jin-Hyun
    Lee, Hye-Soon
    Uhm, Wan-Sik
    Kim, Tae-Hwan
    Jun, Jae-Bum
    Jung, Won-Tae
    Choi, Jung-Yoon
    Kim, Sung-Kyu
    Bae, Sang-Cheol
    Yoo, Dae-Hyun
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S654 - S654
  • [9] New-onset psoriasis following treatment with the interleukin-1 receptor antagonist anakinra
    Gonzalez-Lopez, M. A.
    Martinez-Taboada, V. M.
    Gonzalez-Vela, M. C.
    Fernandez-Llaca, H.
    Val-Bernal, J. F.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (05) : 1146 - 1148
  • [10] Interleukin-1 receptor antagonist ameliorates neonatal lipopolysaccharide-induced long-lasting hyperalgesia in the adult rats
    Wang, Kuo-Ching
    Wang, Su-Jane
    Fan, Lir-Wan
    Cai, Zhengwei
    Rhodes, Philip G.
    Tien, Lu-Tai
    TOXICOLOGY, 2011, 279 (1-3) : 123 - 129